Companies: 10,795·Total market cap: $144.5T
enGene Holdings Inc.

enGene Holdings Inc.

ENGNNASDAQHealthcare● Active
$1.65
+$0.01(+0.30%)
Market Cap$84215737
P/E Ratio—
52W High$12.25
52W Low$1.4
Overview

enGene Holdings Inc. (ENGN) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ENGN · cash on hand · updated Oct 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$193.8M▼ -18.7% vs prior year
FY · as of Oct 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$50.2M
cashAndCashEquivalents
Short-Term Investments
$143.7M
shortTermInvestments
YoY Change vs Prior Year
-18.7%
vs prior fiscal year
Latest Quarter
$275.9M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: October 31, 2025

Net cash vs debt

Cash & ST Investments$193.8MCash on Hand
Total Debt$31.8MTotal Debt
Net Cash / Net Debt+$162.0MNet Cash Position
Cash vs Debt Ratio
Cash 86%Debt 14%

enGene Holdings Inc. has a net cash position of $162.0M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$193.8M − $31.8M = +$162.0M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ENGN annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Oct 31, 2025Latest$193.8M-18.7%
Oct 31, 2024$238.4M+192.2%
Oct 31, 2023$81.6M+25873.8%
Oct 31, 2022$0.3M-70.6%
Oct 31, 2021$1.1M—
ENGN cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
enGene Holdings Inc.
enGene Holdings Inc.YOU
ENGN
$193.8M228.1%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

enGene Holdings Inc. (ENGN) cash on hand as of October 31, 2025 is $193.8M, comprising $50.2M in cash and cash equivalents (CCE) plus $143.7M in short-term investments — reported as enGene Holdings Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as enGene Holdings Inc. cash reserves or cash position.

enGene Holdings Inc. annual cash on hand history shows decreased -18.7% in 2025: decreased -18.7% in 2025. enGene Holdings Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

enGene Holdings Inc. carries total debt of $31.8M against cash of $193.8M, resulting in a net cash position of +$162.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ENGN cash on hand · 5 questions

As of October 31, 2025, enGene Holdings Inc. (ENGN) has $193,815,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $50,152,000 in cash and cash equivalents (CCE) plus $143,663,000 in short-term investments. Latest quarter (January 31, 2026): $275,948,000. Data sourced from the annual 10-K filing via FMP.

ENGN cash on handENGN cash reservesENGN cash 2025how much cash does ENGN have

▸ Source: FMP /balance-sheet-statement · US GAAP · enGene Holdings Inc. · enGene Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: October 31, 2025